Class information for:
Level 1: PCA3//TMPRSS2 ERG//PROSTATE CANCER ANTIGEN 3

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
8778 1218 43.8 91%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
21 4 UROLOGY & NEPHROLOGY//UROL//JOURNAL OF UROLOGY 229838
272 3       PROSTATE CANCER//PROSTATIC NEOPLASMS//UROL 43768
74 2             PROSTATE CANCER//PROSTATIC NEOPLASMS//RADICAL PROSTATECTOMY 27992
8778 1                   PCA3//TMPRSS2 ERG//PROSTATE CANCER ANTIGEN 3 1218

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PCA3 authKW 1661326 7% 82% 81
2 TMPRSS2 ERG authKW 1219760 5% 78% 62
3 PROSTATE CANCER ANTIGEN 3 authKW 605221 2% 93% 26
4 ERG authKW 570527 9% 20% 112
5 TMPRSS2 authKW 523693 3% 67% 31
6 TMPRSS2 ERG FUSION authKW 381301 1% 89% 17
7 SECT TRANSLAT PROSTATE CANC address 370798 2% 53% 28
8 MICHIGAN TRANSLAT PATHOL address 366305 5% 24% 62
9 ERG REARRANGEMENT authKW 325890 1% 100% 13
10 PROSTATE CANCER GENE 3 authKW 302610 1% 93% 13

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Urology & Nephrology 13260 31% 0% 373
2 Oncology 8580 44% 0% 532
3 Pathology 2475 13% 0% 161
4 Cell Biology 292 10% 0% 120
5 Andrology 271 1% 0% 12
6 Endocrinology & Metabolism 258 7% 0% 83
7 Medical Laboratory Technology 217 2% 0% 30
8 Genetics & Heredity 194 7% 0% 81
9 Medicine, Research & Experimental 87 4% 0% 53
10 Biochemistry & Molecular Biology 12 8% 0% 95

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 SECT TRANSLAT PROSTATE CANC 370798 2% 53% 28
2 MICHIGAN TRANSLAT PATHOL 366305 5% 24% 62
3 PROSTATE CANC 193781 5% 12% 62
4 GEN VISCERAL THORAC SURG CLIN 175465 1% 50% 14
5 MARTINI CLIN 141006 4% 13% 44
6 MARTINI CLIN PROSTATE CANC 136522 1% 34% 16
7 UROL 94065 53% 1% 640
8 GRP CANC EPIGENET 75205 0% 100% 3
9 PROSTATE DIS 72206 2% 10% 28
10 ADDARII 60157 0% 40% 6

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PROSTATE 27775 6% 2% 71
2 MODERN PATHOLOGY 8338 3% 1% 40
3 EUROPEAN UROLOGY 8303 4% 1% 49
4 PROSTATE CANCER AND PROSTATIC DISEASES 7506 1% 2% 18
5 ACTAS UROLOGICAS ESPANOLAS 4986 1% 1% 14
6 CURRENT OPINION IN UROLOGY 3750 1% 1% 13
7 BJU INTERNATIONAL 3731 3% 0% 35
8 NATURE REVIEWS UROLOGY 3606 1% 2% 8
9 NEOPLASIA 3324 1% 1% 15
10 CLINICAL CANCER RESEARCH 2386 3% 0% 38

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 PCA3 1661326 7% 82% 81 Search PCA3 Search PCA3
2 TMPRSS2 ERG 1219760 5% 78% 62 Search TMPRSS2+ERG Search TMPRSS2+ERG
3 PROSTATE CANCER ANTIGEN 3 605221 2% 93% 26 Search PROSTATE+CANCER+ANTIGEN+3 Search PROSTATE+CANCER+ANTIGEN+3
4 ERG 570527 9% 20% 112 Search ERG Search ERG
5 TMPRSS2 523693 3% 67% 31 Search TMPRSS2 Search TMPRSS2
6 TMPRSS2 ERG FUSION 381301 1% 89% 17 Search TMPRSS2+ERG+FUSION Search TMPRSS2+ERG+FUSION
7 ERG REARRANGEMENT 325890 1% 100% 13 Search ERG+REARRANGEMENT Search ERG+REARRANGEMENT
8 PROSTATE CANCER GENE 3 302610 1% 93% 13 Search PROSTATE+CANCER+GENE+3 Search PROSTATE+CANCER+GENE+3
9 PROSTATE CANCER ANTIGEN 3 HUMAN 277680 1% 92% 12 Search PROSTATE+CANCER+ANTIGEN+3+HUMAN Search PROSTATE+CANCER+ANTIGEN+3+HUMAN
10 PROSTATE CANCER 242631 42% 2% 508 Search PROSTATE+CANCER Search PROSTATE+CANCER

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 XU, B , CHEVARIE-DAVIS, M , CHEVALIER, S , SCARLATA, E , ZEIZAFOUN, N , DRAGOMIR, A , TANGUAY, S , KASSOUF, W , APRIKIAN, A , BRIMO, F , (2014) THE PROGNOSTIC ROLE OF ERG IMMUNOPOSITIVITY IN PROSTATIC ACINAR ADENOCARCINOMA: A STUDY INCLUDING 454 CASES AND REVIEW OF THE LITERATURE.HUMAN PATHOLOGY. VOL. 45. ISSUE 3. P. 488-497 79 99% 11
2 PETTERSSON, A , GRAFF, RE , BAUER, SR , PITT, MJ , LIS, RT , STACK, EC , MARTIN, NE , KUNZ, L , PENNEY, KL , LIGON, AH , ET AL (2012) THE TMPRSS2:ERG REARRANGEMENT, ERG EXPRESSION, AND PROSTATE CANCER OUTCOMES: A COHORT STUDY AND META-ANALYSIS.CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. VOL. 21. ISSUE 9. P. 1497 -1509 65 84% 81
3 BURDOVA, A , BOUCHAL, J , TAVANDZIS, S , KOLAR, Z , (2014) TMPRSS2-ERG GENE FUSION IN PROSTATE CANCER.BIOMEDICAL PAPERS-OLOMOUC. VOL. 158. ISSUE 4. P. 502 -510 80 83% 5
4 BOSTROM, PJ , BJARTELL, AS , CATTO, JWF , EGGENER, SE , LILJA, H , LOEB, S , SCHALKEN, J , SCHLOMM, T , COOPERBERG, MR , (2015) GENOMIC PREDICTORS OF OUTCOME IN PROSTATE CANCER.EUROPEAN UROLOGY. VOL. 68. ISSUE 6. P. 1033 -1044 67 71% 26
5 LIU, WN , (2016) DNA ALTERATIONS IN THE TUMOR GENOME AND THEIR ASSOCIATIONS WITH CLINICAL OUTCOME IN PROSTATE CANCER.ASIAN JOURNAL OF ANDROLOGY. VOL. 18. ISSUE 4. P. 533 -542 96 59% 2
6 ABOU-OUF, H , ZHAO, LN , BISMAR, TA , (2016) ERG EXPRESSION IN PROSTATE CANCER: BIOLOGICAL RELEVANCE AND CLINICAL IMPLICATION.JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. VOL. 142. ISSUE 8. P. 1781 -1793 81 70% 0
7 FONT-TELLO, A , JUANPERE, N , DE MUGA, S , LORENZO, M , LORENTE, JA , FUMADO, L , SERRANO, L , SERRANO, S , LLORETA, J , HERNANDEZ, S , (2015) ASSOCIATION OF ERG AND TMPRSS2-ERG WITH GRADE, STAGE, AND PROGNOSIS OF PROSTATE CANCER IS DEPENDENT ON THEIR EXPRESSION LEVELS.PROSTATE. VOL. 75. ISSUE 11. P. 1216 -1226 48 96% 12
8 FALZARANO, SM , MAGI-GALLUZZI, C , (2013) ERG PROTEIN EXPRESSION AS A BIOMARKER OF PROSTATE CANCER.BIOMARKERS IN MEDICINE. VOL. 7. ISSUE 6. P. 851-865 69 80% 8
9 VLAEMINCK-GUILLEM, V , (2014) URINARY PCA3 TEST: WHICH PERSPECTIVES?.MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE. VOL. 38. ISSUE 1. P. 21-30 67 85% 0
10 ACS, B , SZARVAS, T , SZEKELY, N , NYIRADY, P , SZASZ, AM , (2015) CURRENT STATE OF ERG AS BIOMARKER IN PROSTATIC ADENOCARCINOMA.CURRENT CANCER DRUG TARGETS. VOL. 15. ISSUE 8. P. 643 -651 81 66% 0

Classes with closest relation at Level 1


Rank Class id link
1 37481 SARCOSINE//SARCOSINE IN URINE//SERUM SARCOSINE
2 37522 DIFFERENTIAL GENE EXPRESSION DETECTION//CANC GENOME DISCOVERY CCGD//CANCER GENE ACTIVATION HETEROGENEITY
3 14360 GSTP1//UNIDAD DOCENTE BIOQUIM BIOL MOL//DNA METHYLATION
4 7669 PROSTATIC INTRAEPITHELIAL NEOPLASIA//AMACR//ALPHA METHYLACYL COA RACEMASE
5 13026 NKX31//LZTS1//HOMEOBOX GENE NKX31
6 1451 ACTIVE SURVEILLANCE//WATCHFUL WAITING//PROSTATE SPECIFIC ANTIGEN
7 1876 ANDROGEN RECEPTOR//GEORGE WHIPPLE CANC//CASTRATION RESISTANT PROSTATE CANCER
8 19243 TRANS SPLICING//SPLICED LEADER//CHIMERIC RNA
9 8040 HEREDITARY PROSTATE CANCER//RNASEL//8Q24
10 976 PROSTATE SPECIFIC ANTIGEN//FREE PSA//PSA

Go to start page